Sua seleção (0)
Detalhe da pesquisa
1.
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations.
Cell;
148(1-2): 59-71, 2012 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22265402
2.
Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma.
Clin Cancer Res;
21(22): 5100-9, 2015 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26202950
3.
The landscape of genomic alterations across childhood cancers.
Nature;
555(7696): 321-327, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29489754
4.
Author Correction: The landscape of genomic alterations across childhood cancers.
Nature;
559(7714): E10, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29875405
5.
Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease.
Pediatr Blood Cancer;
: e28061, 2019 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31736229
6.
Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.
Clin Cancer Res;
23(12): e62-e67, 2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28620006
7.
Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders.
Clin Cancer Res;
23(11): e23-e31, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28572264
8.
p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy.
Clin Cancer Res;
23(21): 6629-6639, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28821555
9.
Retinoblastoma and Neuroblastoma Predisposition and Surveillance.
Clin Cancer Res;
23(13): e98-e106, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28674118
10.
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.
Nature;
483(7391): 589-93, 2012 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22367537
11.
From class waivers to precision medicine in paediatric oncology.
Lancet Oncol;
18(7): e394-e404, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28677575
12.
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin.
Int J Cancer;
136(6): 1308-20, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25046253
13.
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification.
Proc Natl Acad Sci U S A;
109(47): 19190-5, 2012 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23091029
14.
Prevalence and clinical implications of chromothripsis in cancer genomes.
Curr Opin Oncol;
26(1): 64-72, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24305569
15.
Copy number defects of G1-cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis.
Genes Chromosomes Cancer;
51(1): 10-9, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22034077
16.
Identification of BIRC6 as a novel intervention target for neuroblastoma therapy.
BMC Cancer;
12: 285, 2012 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22788920
17.
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.
Clin Cancer Res;
17(24): 7684-92, 2011 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22031095
18.
Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells.
Proc Natl Acad Sci U S A;
106(31): 12968-73, 2009 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-19525400
19.
A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.
Mol Cancer;
9: 185, 2010 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20624283
20.
Towards personalized therapy in pediatric acute lymphoblastic leukemia: RAS mutations and prednisolone resistance.
Haematologica;
100(4): e132-6, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25480501